VivoSeq
Other

Hemodynamic Response

0

Pipeline Programs↗

2

Active Trials↗

2

Companies Involved↗

Hemodynamic Response is an early-stage landscape with 0 programs across 2 companies. The most active players are Cumberland Pharmaceuticals, PhaseBio Pharmaceuticals Inc..

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

3/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

C

Cumberland Pharmaceuticals

0 programs

PreclinicalP

PhaseBio Pharmaceuticals Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

35

clinical trials

Completed17 · 49%
Unknown status15 · 43%
Not yet recruiting1 · 3%
Recruiting1 · 3%
Terminated1 · 3%

Clinical Trials

Trial Activity

35 trials

Effect of Dexmedetomidine on Hemodynamic Response to Endotracheal Intubation in Hypertensive Patients
Recruiting·LLiaquat National Hospital & Medical College·Phase 1/2·NCT06712186·60 enrolled
Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients
Not yet recruiting·TTanta University·Phase 2/3·NCT06935292·70 enrolled
Preoperative Ephedrine Attenuates the Hemodynamic Responses of Propofol During Valve Surgery: A Dose Dependent Study
Completed·KKing Faisal University·Phase 2·NCT01006863·150 enrolled
Comparison of Effects of Scalp Block and Intravenous Esmolol on Hemodynamic Response Following the Skull Pins Application for Elective Supratentorial Craniotomy
Completed·KKhon Kaen University·N/A·NCT06268275·90 enrolled
A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients
Completed·CCumberland Pharmaceuticals·Phase 2·NCT00592475·20 enrolled
Comparison of Dexmedetomidine and Fentanyl to Prevent Hemodynamic Response to Skull Pins Application
Completed·KKhon Kaen University·Phase 4·NCT03077503·60 enrolled
The EC50 of Remifentanil Blunting Hemodynamic Response to Double Lumen Tube Intubation
Completed·SSeoul National University Hospital·N/A·NCT01542099·80 enrolled
Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo
Completed·VVIVUS LLC·Phase 1·NCT01616485·106 enrolled
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
Completed·UUniversity of California, San Francisco·Phase 4·NCT01869699·41 enrolled
Dexmedetomidine or Lidocaine for Lessening the Hemodynamic Responses to Laryngoscopy and Intubation
Completed·ZZagazig University·N/A·NCT05941767·100 enrolled
Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Completed·—·N/A·NCT06107543·94 enrolled
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
Completed·PPhaseBio Pharmaceuticals Inc.·Phase 1·NCT03315507·3 enrolled
Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study
Completed·SSindh Institute of Urology and Transplantation·Phase 4·NCT05909215·105 enrolled
Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation
Completed·—·N/A·NCT07348159·107 enrolled
Comparison of Dexmedetomidin and Remifentanil for the Effect on Airway Reflex and Hemodynamic Response During Emergence in Patients Undergoing Craniotomy
Completed·YYonsei University·Phase 4·NCT01365923·74 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)